A Phase II, Open-Label, Multicenter, Basket Study of the ATR Kinase Inhibitor ART0380 Administered Orally As Monotherapy to Patients with Biologically Selected Advanced or Metastatic Solid Tumors (ARTIST)
GYNECOLOGIC ONCOLOGY(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined